SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

25 Apr 2024 Evaluate
The sales slipped to Rs. 5365.97 millions for the March 2024 quarter as against Rs. 6213.20 millions during the year-ago period.The Company to register a -33.08%  fall in the net profit for the quarter ended March 2024.The Operating Profit of the company witnessed a decrease to 1445.77 millions from 2092.66 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 5365.97 6213.20 -13.64 22832.14 21612.20 5.64 22832.14 21612.20 5.64
Other Income 31.31 28.36 10.40 120.42 289.57 -58.41 120.42 289.57 -58.41
PBIDT 1445.77 2092.66 -30.91 6862.88 6712.50 2.24 6862.88 6712.50 2.24
Interest 3.64 1.19 205.88 15.46 5.47 182.63 15.46 5.47 182.63
PBDT 1442.13 2091.47 -31.05 6847.42 6707.03 2.09 6847.42 6707.03 2.09
Depreciation 145.34 115.17 26.20 534.52 420.94 26.98 534.52 420.94 26.98
PBT 1296.79 1976.30 -34.38 6312.90 6286.09 0.43 6312.90 6286.09 0.43
TAX 317.42 512.73 -38.09 1604.02 1616.48 -0.77 1604.02 1616.48 -0.77
Deferred Tax 6.88 39.62 -82.64 81.88 110.37 -25.81 81.88 110.37 -25.81
PAT 979.37 1463.57 -33.08 4708.88 4669.61 0.84 4708.88 4669.61 0.84
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 245.05 0.00
PBIDTM(%) 26.94 33.68 -20.00 30.06 31.06 -3.22 30.06 31.06 -3.22

Alivus Life Sciences Share Price

1066.65 -6.50 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×